Suppression of adaptive immune cell activation does not alter innate immune adipose inflammation or insulin resistance in obesity

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Subramanian, Manikandan ^a   Ozcan, Lale ^a   Ghorpade, Devram Sampat ^a   Ferrante, Anthony W ^a   Tabas, Ira ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GLUCOSE; GLYCOPROTEIN P 15095; INSULIN; MYELOID DIFFERENTIATION FACTOR 88; CD11 ANTIGEN; MYD88 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM;

ANIMALS; ANTIGENS, CD11; IMMUNITY, INNATE; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; OBESITY;

EID: 84943328566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135842     Document Type: Article

References (49)

1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-6. Epub 2006/12/15. doi: nature05482 [pii] doi: 10.1038/nature05482 PMID: 17167471.
2. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415-45. Epub 2011/01/12. doi: 10.1146/annurev-immunol-031210-101322 PMID: 21219177.
3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-808. Epub 2003/12/18. doi: 10.1172/JCI19246 112/12/1796 [pii]. PMID: 14679176; PubMed Central PMCID: PMC296995.
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821-30. Epub 2003/12/18. doi: 10.1172/JCI19451 112/12/1821 [pii]. PMID: 14679177; PubMed Central PMCID: PMC296998.
5. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alphafunction. Nature. 1997;389(6651):610-4. Epub 1997/10/23 22:33. doi: 10.1038/39335 PMID: 9335502.
6. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51(12):3391-9. Epub 2002/11/28. PMID: 12453891.
7. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008;8(4):301-9. Epub 2008/10/09. doi: S1550-4131 (08) 00282-9 [pii] doi: 10.1016/j.cmet.2008.08.015 PMID: 18840360; PubMed Central PMCID: PMC2630775.
8. Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, Andre M, et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett. 2005;579(17):3487-92. Epub 2005/06/15. doi: S0014-5793 (05) 00621-6 [pii] doi: 10.1016/j.febslet.2005.05.031 PMID: 15953605.
9. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. ArteriosclerThromb Vasc Biol. 2008;28(7):1304-10. Epub 2008/04/19. doi: ATVBAHA.108.165100 [pii] doi: 10.1161/ATVBAHA.108.165100 PMID: 18420999.
10. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009;15(8):930-9. Epub 2009/07/28. doi: nm.2002 [pii] doi: 10.1038/nm.2002 PMID: 19633656; PubMed Central PMCID: PMC3115752.
11. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009;15(8):921-9. Epub 2009/07/28. doi: nm.2001 [pii] doi: 10.1038/nm.2001 PMID: 19633657; PubMed Central PMCID: PMC3063199.
12. Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol. 2010;185(3):1836-45. Epub 2010/06/29. doi: jimmunol.1000021 [pii] doi: 10.4049/jimmunol.1000021 PMID: 20581149.
13. Ballak DB, Stienstra R, Hijmans A, Joosten LA, Netea MG, Tack CJ. Combined B- and T-cell deficiency does not protect against obesity-induced glucose intolerance and inflammation. Cytokine. 2013;62(1):96-103. Epub 2013/03/13. doi: S1043-4666 (13) 00062-8 [pii] doi: 10.1016/j.cyto.2013.02.009 PMID: 23478176.
14. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914-20. Epub 2009/07/28. doi: nm.1964 [pii] doi: 10.1038/nm. 1964 PMID: 19633658.
15. Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET, et al. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab. 2013;17(4):520-33. Epub 2013/04/09. doi: S1550-4131 (13) 00105-8 [pii] doi: 10.1016/j.cmet.2013.02.019 PMID: 23562076; PubMed Central PMCID: PMC3685808.
16. Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C, et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA. 2013;110(32):13079-84. Epub 2013/07/24. doi: 1311557110 [pii] doi: 10.1073/pnas. 1311557110 PMID: 23878227; PubMed Central PMCID: PMC3740863.
17. Cho KW, Morris DL, Del Proposto JL, Geletka L, Zamarron B, Martinez-Santibanez G, et al. An MHC II-Dependent Activation Loop between Adipose Tissue Macrophages and CD4 T Cells Controls Obesity-Induced Inflammation. Cell reports. 2014. doi: 10.1016/j.celrep. 2014.09.004 PMID: 25310975.
18. De Furia J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA. 2013;110(13):5133-8. Epub 2013/03/13. doi: 1215840110 [pii] doi: 10.1073/pnas.1215840110 PMID: 23479618; PubMed Central PMCID: PMC3612635.
19. Hou B, Reizis B, De Franco AL. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and-extrinsic mechanisms. Immunity. 2008;29(2):272-82. Epub 2008/07/29. doi: S1074-7613 (08) 00315-4 [pii] doi: 10.1016/j.immuni.2008.05.016 PMID: 18656388; PubMed Central PMCID: PMC2847796.
20. Subramanian M, Thorp E, Hansson GK, Tabas I. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J Clin Invest. 2013;123(1):179-88. Epub 2012/12/22. doi: 64617 [pii] doi: 10.1172/JCI64617 PMID: 23257360; PubMed Central PMCID: PMC3533292.
21. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4T cells in the whole body. Nature. 2001;410(6824):101-5. Epub 2001/03/10. doi: 10.1038/35065111 [pii]. PMID: 11242050.
22. Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluoresceindiacetatesuccinimidyl ester. Nat Protoc. 2007;2(9):2049-56. Epub 2007/09/15. doi: nprot.2007.296 [pii] doi: 10.1038/nprot.2007.296 PMID: 17853860.
23. Stefanovic-Racic M, Yang X, Turner MS, Mantell BS, Stolz DB, Sumpter TL, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+cells in adipose tissue and liver. Diabetes. 2012;61(9):2330-9. Epub 2012/08/02. doi: db11-1523 [pii] doi: 10.2337/db11-1523 PMID: 22851575; PubMed Central PMCID: PMC3425427.
24. Morris DL, Cho KW, Delproposto JL, Oatmen KE, Geletka LM, Martinez-Santibanez G, et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes. 2013;62(8):2762-72. Epub 2013/03/16. doi: db12-1404 [pii] doi: 10.2337/db12-1404 PMID: 23493569; PubMed Central PMCID: PMC3717880.
25. Bertola A, Ciucci T, Rousseau D, Bourlier V, Duffaut C, Bonnafous S, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238-47. Epub 2012/05/19. doi: db11-1274 [pii] doi: 10. 2337/db11-1274 PMID: 22596049; PubMed Central PMCID: PMC3425417.
26. Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol. 2012;13(11):1118-28. Epub 2012/10/02. doi: ni.2419 [pii] doi: 10.1038/ni.2419 PMID: 23023392; PubMed Central PMCID: PMC3558276.
27. Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol. 2006;176(2):803-10. Epub 2006/01/06. doi: 176/2/803 [pii]. PMID: 16393963.
28. Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998;76(1):34-40. Epub 1998/04/29. doi: 10.1046/j.1440-1711.1998. 00709.x PMID: 9553774.
29. Mantegazza AR, Zajac AL, Twelvetrees A, Holzbaur EL, Amigorena S, Marks MS. TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation. Proc Natl Acad Sci USA. 2014. doi: 10.1073/pnas.1412998111 PMID: 25313083.
30. Goldrath AW, Luckey CJ, Park R, Benoist C, Mathis D. The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci USA. 2004;101(48):16885-90. Epub 2004/11/19. doi: 0407417101 [pii] doi: 10.1073/pnas.0407417101 PMID: 15548615; PubMed Central PMCID: PMC534746.
31. Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ, et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab. 2013;17(3):411-22. Epub 2013/03/12. doi: S1550-4131 (13) 00057-0 [pii] doi: 10.1016/j.cmet.2013.02.009 PMID: 23473035; PubMed Central PMCID: PMC3619392.
32. Amoras AL, Kanegane H, Miyawaki T, Vilela MM. Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. Journal of investigational allergology & clinical immunology. 2003;13(3):181-8. PMID: 14635468.
33. Khare A, Viswanathan B, Gund R, Jain N, Ravindran B, George A, et al. Role of Bruton's tyrosine kinase in macrophage apoptosis. Apoptosis: an international journal on programmed cell death. 2011;16(4):334-46. doi: 10.1007/s10495-010-0569-6 PMID: 21193961.
34. Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P, et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol. 2011;12(5):416-24. doi: 10.1038/ni.2015 PMID: 21441935.
35. Melcher M, Unger B, Schmidt U, Rajantie IA, Alitalo K, Ellmeier W. Essential roles for the Tec family kinases Tec and Btk in M-CSF receptor signaling pathways that regulate macrophage survival. J Immunol. 2008;180(12):8048-56. PMID: 18523268; PubMed Central PMCID: PMC3001193.
36. Montes VN, Turner MS, Subramanian S, Ding Y, Hayden-Ledbetter M, Slater S, et al. Tcell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS One. 2013;8(7):e67709. Epub 2013/07/12. doi: 10.1371/journal.pone.0067709 PONE-D-13-05869 [pii]. PMID: 23844072; PubMed Central PMCID: PMC3699637.
37. Vasanthakumar A, Moro K, Xin A, Liao Y, Gloury R, Kawamoto S, et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol. 2015;16(3):276-85. doi: 10.1038/ni.3085 PMID: 25599561.
38. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479-90. doi: 10.1016/j.immuni.2005.09.015 PMID: 16286016.
39. Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, et al. IL-33 expands suppressive CD11b+Gr-1 (int) and regulatory T cells, including ST2L+ Foxp3+cells, and mediates regulatory T celldependent promotion of cardiac allograft survival. J Immunol. 2011;187(9):4598-610. doi: 10.4049/jimmunol.1100519 PMID: 21949025; PubMed Central PMCID: PMC3197898.
40. Xia S, Sha H, Yang L, Ji Y, Ostrand-Rosenberg S, Qi L. Gr-1+CD11b+myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. The Journal of biological chemistry. 2011;286(26):23591-9. doi: 10.1074/jbc. M111.237123 PMID: 21592961; PubMed Central PMCID: PMC3123122.
41. Takeuchi O, Akira S. MyD88asabottleneck in Toll/IL-1 signaling. Curr Top Microbiol Immunol. 2002;270:155-67. Epub 2002/12/07. PMID: 12467250.
42. Kleinridders A, Schenten D, Konner AC, Belgardt BF, Mauer J, Okamura T, et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 2009;10(4):249-59. Epub 2009/10/08. doi: S1550-4131 (09) 00263-0 [pii] doi: 10.1016/j. cmet.2009.08.013 PMID: 19808018; PubMed Central PMCID: PMC3898351.
43. Hosoi T, Yokoyama S, Matsuo S, Akira S, Ozawa K. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoSOne. 2010;5 (9). Epub 2010/09/09. doi: 10.1371/journal.pone.0012537 PMID: 20824098; PubMed Central PMCID: PMC2932727.
44. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al. Pro-inflammatory CD11c +CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010;59(7):1648-56. Epub 2010/04/02. doi: db09-0287 [pii] doi: 10.2337/db09-0287 PMID: 20357360; PubMed Central PMCID: PMC2889764.
45. Yu M, Zhou H, Zhao J, Xiao N, Roychowdhury S, Schmitt D, et al. MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases. J Exp Med. 2014;211(5):887-907. Epub 2014/04/23. doi: jem.20131314 [pii] doi: 10.1084/jem. 20131314 PMID: 24752299; PubMed Central PMCID: PMC4010914.
46. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, et al. Role of adaptorTRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003;301(5633):640-3. Epub 2003/07/12. doi: 10.1126/science. 1087262 [pii]. PMID: 12855817.
47. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acidinduced insulin resistance. J Clin Invest. 2006;116(11):3015-25. Epub 2006/10/21. doi: 10.1172/JCI28898 PMID: 17053832; PubMed Central PMCID: PMC1616196.
48. Wu LH, Huang CC, Adhikarakunnathu S, San Mateo LR, Duffy KE, Rafferty P, et al. Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice. Metabolism. 2012;61(11):1633-45. Epub 2012/05/23. doi: S0026-0495 (12) 00173-4 [pii] doi: 10.1016/j.metabol. 2012.04.015 PMID: 22607770.
49. Deng ZB, Poliakov A, Hardy RW, Clements R, Liu C, Liu Y, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes. 2009;58(11):2498-505. Epub 2009/08/14. doi: db09-0216 [pii] doi: 10.2337/db09-0216 PMID: 19675137; PubMed Central PMCID: PMC2768161.